Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family Flaviviridae

Thomas S. Postler, Martin Beer, Bradley J. Blitvich, Jens Bukh, Xavier de Lamballerie, J. Felix Drexler, Allison Imrie, Amit Kapoor, Galina G. Karganova, Philippe Lemey, Volker Lohmann, Peter Simmonds, Donald B. Smith, Jack T. Stapleton, Jens H. Kuhn*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftReviewpeer review

102 Citationer (Scopus)

Abstract

This review provides a summary of the recently ratified changes to genus and species nomenclature within the virus family Flaviviridae along with reasons for these changes. First, it was considered that the vernacular terms “flaviviral”, “flavivirus”, and “flaviviruses” could under certain circumstances be ambiguous due to the same word stem “flavi” in the taxon names Flaviviridae and Flavivirus; these terms could either have referred to all viruses classified in the family Flaviviridae or only to viruses classified in the included genus Flavivirus. To remove this ambiguity, the genus name Flavivirus was changed to Orthoflavivirus by the International Committee on Taxonomy of Viruses (ICTV). Second, all species names in the family were changed to adhere to a newly ICTV-mandated binomial format (e.g., Orthoflavivirus zikaense, Hepacivirus hominis) similar to nomenclature conventions used for species elsewhere in biology. It is important to note, however, that virus names remain unchanged. Here we outline the revised taxonomy of the family Flaviviridae as approved by the ICTV in April 2023.

OriginalsprogEngelsk
Artikelnummer224
TidsskriftArchives of Virology
Vol/bind168
Udgave nummer9
ISSN0304-8608
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
This work was supported in part through Laulima Government Solutions, LLC, prime Contract No. HHSN272201800013C with the U.S. National Institute of Allergy and Infectious Diseases (NIAID). J.H.K. performed this work as an employee of Tunnell Government Services (TGS), a subcontractor of Laulima Government Solutions, LLC, under Contract No. HHSN272201800013C. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Health and Human Services or of the institutions and companies affiliated with the authors.

Funding Information:
We thank Anya Crane (NIH NIAID DCR IRF-Frederick) for critically editing the manuscript.

Publisher Copyright:
© 2023, Springer-Verlag GmbH Austria, part of Springer Nature.

Citationsformater